TY - JOUR
T1 - Decoupling of motor cortex to movement in Parkinson's dyskinesia rescued by sub-anaesthetic ketamine
AU - Vishwanath, Abhilasha
AU - Bartlett, Mitchell J.
AU - Falk, Torsten
AU - Cowen, Stephen L.
N1 - Publisher Copyright:
© 2024 The Author(s).
PY - 2025/6/1
Y1 - 2025/6/1
N2 - Gamma-band and single-unit neural activity in primary motor cortex are involved in the control of movement. This activity is disrupted in Parkinsons disease (PD) and levodopa-induced dyskinesia (LID), a debilitating consequence of dopamine replacement therapy for PD. Physiological features of LID include pathological narrowband gamma oscillations, finely tuned gamma and altered primary motor cortex firing activity. Given that most studies characterize LID through visual scoring, little is known about the relationships between ongoing dyskinetic movements, gamma and neuronal activity at fast (sub-second) and slow (seconds) time scales. Here, we investigate how motor cortex activity changes with movement at multiple time scales in animal models of PD and LID. Furthermore, sub-anaesthetic ketamine has emerged as a possible therapy for LID. How ketamine might reduce LID is not fully understood. Consequently, we investigate how ketamine affects the relationship between motor cortex activity and movement. To investigate these questions, local-field and single-unit activity from >3000 motor cortex neurons was acquired using a standard model of PD/LID (n = 10 male rats). Data in LID and sham animals were acquired following levodopa (L-DOPA; 12 mg/kg, intraperitoneal) and ketamine (20 mg/kg, intraperitoneal) administration. Movement was assessed using traditional abnormal involuntary movement scores and head-mounted inertial sensors sampled at 200 Hz. Although correlations between movement, gamma and single-unit activity were high in all animals during control conditions, correlations decreased considerably in animal models of LID following L-DOPA administration. This suggests that primary motor cortex can become functionally decoupled from ongoing movements in LID. Interestingly, this effect was observed in both the dopamine-depleted and non-depleted hemispheres. Ketamine disrupted finely tuned gamma, decreased LID and moderately increased single-unit correlations with movement during LID. Ketamine, however, did not enhance the correlation between gamma-band activity and movement. Finally, ketamine exerted a selective effect on neuronal interactions and ensemble activity in LID animals. Specifically, analysis of cell-pair firing-rate correlations showed that ketamine induced a distinct neural ensemble state in LID by reorganizing the pattern of cell-pair interactions. These findings provide insight into the role that motor cortex neurons and gamma-band activity play during healthy movement and LID. Results suggest that primary motor cortex does not directly trigger specific dyskinetic movements during LID but, instead, dysregulated motor cortex activity might permit aberrant movements to emerge spontaneously in downstream circuits. These data further support the anti-dyskinetic properties of ketamine and suggest that ketamine acts to reduce LID by disrupting pathological interactions between motor cortex neurons during dyskinesia.
AB - Gamma-band and single-unit neural activity in primary motor cortex are involved in the control of movement. This activity is disrupted in Parkinsons disease (PD) and levodopa-induced dyskinesia (LID), a debilitating consequence of dopamine replacement therapy for PD. Physiological features of LID include pathological narrowband gamma oscillations, finely tuned gamma and altered primary motor cortex firing activity. Given that most studies characterize LID through visual scoring, little is known about the relationships between ongoing dyskinetic movements, gamma and neuronal activity at fast (sub-second) and slow (seconds) time scales. Here, we investigate how motor cortex activity changes with movement at multiple time scales in animal models of PD and LID. Furthermore, sub-anaesthetic ketamine has emerged as a possible therapy for LID. How ketamine might reduce LID is not fully understood. Consequently, we investigate how ketamine affects the relationship between motor cortex activity and movement. To investigate these questions, local-field and single-unit activity from >3000 motor cortex neurons was acquired using a standard model of PD/LID (n = 10 male rats). Data in LID and sham animals were acquired following levodopa (L-DOPA; 12 mg/kg, intraperitoneal) and ketamine (20 mg/kg, intraperitoneal) administration. Movement was assessed using traditional abnormal involuntary movement scores and head-mounted inertial sensors sampled at 200 Hz. Although correlations between movement, gamma and single-unit activity were high in all animals during control conditions, correlations decreased considerably in animal models of LID following L-DOPA administration. This suggests that primary motor cortex can become functionally decoupled from ongoing movements in LID. Interestingly, this effect was observed in both the dopamine-depleted and non-depleted hemispheres. Ketamine disrupted finely tuned gamma, decreased LID and moderately increased single-unit correlations with movement during LID. Ketamine, however, did not enhance the correlation between gamma-band activity and movement. Finally, ketamine exerted a selective effect on neuronal interactions and ensemble activity in LID animals. Specifically, analysis of cell-pair firing-rate correlations showed that ketamine induced a distinct neural ensemble state in LID by reorganizing the pattern of cell-pair interactions. These findings provide insight into the role that motor cortex neurons and gamma-band activity play during healthy movement and LID. Results suggest that primary motor cortex does not directly trigger specific dyskinetic movements during LID but, instead, dysregulated motor cortex activity might permit aberrant movements to emerge spontaneously in downstream circuits. These data further support the anti-dyskinetic properties of ketamine and suggest that ketamine acts to reduce LID by disrupting pathological interactions between motor cortex neurons during dyskinesia.
KW - 6-hydroxydopamine hemi-lesioned model
KW - cell types
KW - in vivo electrophysiology
KW - inertial speed
KW - population state
UR - http://www.scopus.com/inward/record.url?scp=105008301527&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=105008301527&partnerID=8YFLogxK
U2 - 10.1093/brain/awae386
DO - 10.1093/brain/awae386
M3 - Article
C2 - 39585797
AN - SCOPUS:105008301527
SN - 0006-8950
VL - 148
SP - 2135
EP - 2150
JO - Brain
JF - Brain
IS - 6
ER -